The phenotype and genotype of fibrodysplasia ossificans progressiva in China: A report of 72 cases

Bone

Volumn 57, Issue 2, 2013, Pages 386-391

  Zhang, Wei ^a,e   Zhang, Keqin ^b   Song, Lige ^b   Pang, Jing ^b   Ma, Hongxing ^b   Shore, Eileen M ^c   Kaplan, Frederick S ^c,d   Wang, Peijun ^b  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e First People's Hospital of Lianyungang   (China)

Author keywords

ACVR1; ALK2; Bone morphogenetic protein; Fibrodysplasia ossificans progressiva; Heterotopic ossification

Indexed keywords

ACVR1 GENE; ADULT; ALK2 GENE; ARTICLE; BONE BIOPSY; BONE RADIOGRAPHY; BONE SCINTISCANNING; CHINA; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; GENE; GENE MUTATION; GENETIC DISORDER; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HETEROTOPIC OSSIFICATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; SKELETON MALFORMATION;

ACVR1; ALK2; BONE MORPHOGENETIC PROTEIN; FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; HETEROTOPIC OSSIFICATION;

BONE AND BONES; CHINA; DISEASE PROGRESSION; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MYOSITIS OSSIFICANS; YOUNG ADULT;

EID: 84884915956     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.09.002     Document Type: Article

References (36)

1. Kaplan F.S., LeMerrer M., Glaser D.L., Pignolo R.J., Goldsby R.E., Kitterman J.A., et al. Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol 2008, 22:191-205.
2. Shore E.M., Feldman G.J., Xu M., Kaplan F.S. The genetics of fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 2005, 3:201-204.
3. Cohen R.B., Hahn G.V., Tabas J.A., Peeper J., Levitz C.L., Sando A., et al. The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressive. J Bone Joint Surg Am 1993, 75:215-219.
4. Kitterman J.A., Kantanie S., Rocke D.M., Kaplan F.S. Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Pediatrics 2005, 116:654-661.
5. Kaplan F.S., Glaser D.L. Thoracic insufficiency syndrome in patients with fibrodysplasia ossificans progressiva. Clin Rev Bone Miner Metab 2005, 3:213-216.
6. Kaplan F.S., Zasloff M.A., Kitterman J.A., Shore E.M., Hong C.C., Rocke D.M. Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva. J Bone Joint Surg Am 2010, 92:686-691.
7. Kaplan F.S., Xu M., Seemann P., Connor J.M., Glaser D.L., Carroll L., et al. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat 2009, 30:379-390.
8. Kaplan F.S., Xu M., Glaser D.L., Collins F., Connor M., Kitterman J., et al. Early diagnosis of fibrodysplasia ossificans progressiva. Pediatrics 2008, 121:e1295-e1300.
9. Shore E.M., Xu M., Feldman G.J., Fenstermacher D.A., Cho T.-J., Choi I.H., et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 2006, 38:525-527.
10. Shen Q., Little S.C., Xu M., Haupt J., Ast C., Katagiri T., et al. The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. J Clin Invest 2009, 119:3462-3472.
11. Kaplan F.S., Pignolo R.J., Shore E.M. The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling. Cytokine Growth Factor Rev 2009, 20:399-407.
12. Kaplan F.S., Lounev V.Y., Wang H., Pignolo R.J., Shore E.M. Fibrodysplasia ossificans progressiva: a blueprint for the metamorphosis. Ann NY Acad Sci 2011, 1237:5-10.
13. Chaikuad A., Alfano I., Kerr G., Sanvitale C.E., Boergermann J.H., Triffitt J.T., et al. Structure of the bone morphogenetic protein receptor ALK2 and implications for fibrodysplasia ossificans progressiva. J Biol Chem 2012, 287:36990-36998.
14. Chakkalakal S.A., Zhang D., Culbert A.L., Convente M.R., Caron R.J., Wright A.C., et al. An ACVR1 knock-in mouse has fibrodysplasia ossificans progressiva. J Bone Miner Res 2012, 27:1746-1756.
15. Kaplan F.S., Chakkalakal S.A., Shore E.M. Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis. Dis Model Mech 2012, 5:756-762.
16. Zhou Q., Meng Y., Su L., Zhao S.M., Shi H.P., Huang S.Z. A Chinese girl with fibrodysplasia ossificans progressiva caused by a de novo mutation R206H in ACVR1 gene. Zhonghua Er Ke Za Zhi 2008, 46:215-219.
17. Sun Y., Xia W., Jiang Y., Xing X., Li M., Wang O., et al. A recurrent mutation c.617G>A in the ACVR1 gene causes fibrodysplasia ossificans progressiva in two Chinese patients. Calcif Tissue Int 2009, 84:361-365.
18. Guo H., Peng D., Xu M., Xue J., Lu L., Xu X., et al. Report of two FOP cases with 617G>A mutation in the ACVR1 gene from Chinese population. Clin Dysmorphol 2010, 19:206-208.
19. Du J., Huang L.L., Tan Y.Q., Cheng D.H., Li S.F., Li L.Y., et al. Mutation analysis and prenatal exclusion of fibrodysplasia ossificans progressiva in a Chinese fetus. Genet Test Mol Biomarkers 2010, [Epub ahead of print]. 10.1089/gtmb.2009.0084.
20. Zhang W., Pan Y., Zhu X., Zhang K. Novel mutation G356D in ACVR1 in fibrodysplasia ossificans progressiva. Prog Mod Biomed 2011, 11:707-710.
21. Zhang W., Zhang W., Zhang K. A novel mutation c.774G>C in the ACVR1 gene causes fibrodysplasia ossificans progressiva in one Chinese patient. J Nanjing Med Univ 2012, 32:62-66.
22. Araújo J.P., Lourenço P., Azevedo A., Friões F., Rocha-Gonçalves F., Ferreira A., et al. Prognostic value of high-sensitivity C-reactive protein in heart failure: a systematic review. J Card Fail 2009, 15:256-266.
23. Bocciardi R., Bordo D., Di Duca M., Di Rocco M., Ravazzolo R. Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements. Eur J Hum Genet 2009, 17:311-318.
24. Morales-Piga A., Bachiller-Corral J., Trujillo-Tiebas M.J., Villaverde-Hueso A., Gamir-Gamir M.L., Alonso-Ferreira V., et al. Fibrodysplasia ossificans progressiva in Spain: epidemiological, clinical, and genetic aspects. Bone 2012, 51:748-755.
25. Furuya H., Ikezoe K., Wang L., Ohyagi Y., Motomura K., Fujii N., et al. A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H). Am J Med Genet 2008, 146A:459-463.
26. Fukuda T., Kohda M., Kanomata K., Nojima J., Nakamura A., Kamizono J., et al. Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. J Biol Chem 2009, 284:7149-7156.
27. Lee D.Y., Cho T.J., Lee H.R., Park M.S., Yoo W.J., Chung C.Y., et al. ACVR1 gene mutation in sporadic Korean patients with fibrodysplasia ossificans progressiva. J Korean Med Sci 2009, 24:433-437.
28. Carvalho D.R., Navarro M.M., Martins B.J., Coelho K.E., Mello W.D., Takata R.I., et al. Mutational screening of ACVR1 gene in Brazilian fibrodysplasia ossificans progressiva patients. Clin Genet 2010, 77:171-176.
29. Dandara C., Scott C., Urban M., Fieggen K., Arendse R., Beighton P. Confirmation of the recurrent ACVR1 617G>A mutation in South Africans with fibrodysplasia ossificans progressiva. S Afr Med J 2012, 102:631-633.
30. Raees-Karami S.R., Jafarieh H., Ziyayi V., Shekarriz Foumani R., Aghighi Y. Evaluation of 20years experience of fibrodysplasia ossificans progressiva in Iran: lessons for early diagnosis and prevention. Clin Rheumatol 2012, 31:1133-1137.
31. Eresen Yazicioǧlu C., Karatosun V., Kizildaǧ S., Ozsoylu D., Kavukçu S. ACVR1 gene mutations in four Turkish patients diagnosed as fibrodysplasia ossificans progressiva. Gene 2013, 515:444-446.
32. Kaplan F.S., Tabas J., Gannon F.H., Finkel G., Hahn G.V., Zasloff M.A. The histopathology of fibrodysplasia ossificans progressiva: an endochondral process. J Bone Joint Surg 1993, 75:220-230.
33. Pignolo R.J., Suda R.K., Kaplan F.S. The fibrodysplasia ossificans progressiva lesion. Clin Rev Bone Miner Metab 2005, 3:195-200.
34. Kaplan F.S., Glaser D.L., Shore E.M., Pignolo R.J., Xu M., Zhang Y., et al. Hematopoietic stem-cell contribution to ectopic skeletogenesis. J Bone Joint Surg Am 2007, 89:347-357.
35. Kaplan F.S., Strear C.M., Zasloff M.A. Radiographic and scintigraphic features of modeling and remodeling in the heterotopic skeleton of patients who have fibrodysplasia ossificans progressiva. Clin Orthop Rel Res 1994, 304:238-247.
36. Mahboubi S., Glaser D.L., Shore E.M., Kaplan F.S. Fibrodysplasia ossificans progressiva. Pediatr Radiol 2001, 31:307-314.